Product
RM-004
1 clinical trial
3 indications
Indication
HemoglobinopathiesIndication
Hereditary DiseasesClinical trial
Study to Evaluate the Safety and Efficacy of RM-004 Cells for the Treatment of Hemoglobin H-Constant Spring DiseaseStatus: Recruiting, Estimated PCD: 2025-10-31